Profil
Yasuo Fujii is Director at Orchard Therapeutics Plc since 2024.
Mr. Fujii is Chief Strategy Officer at Kyowa Kirin Co., Ltd. since 2023.
Formerly, Mr. Fujii was Executive Vice President-Corporate Planning at Kyowa Kirin International Plc.
Mr. Fujii earned an MBA from the University of Illinois.
Aktive Positionen von Yasuo Fujii
| Unternehmen | Position | Beginn |
|---|---|---|
| KYOWA KIRIN CO., LTD. | Corporate Officer/Principal | 01.04.1988 |
| ORCHARD THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 24.01.2024 |
Ehemalige bekannte Positionen von Yasuo Fujii
| Unternehmen | Position | Ende |
|---|---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases | Corporate Officer/Principal | - |
Ausbildung von Yasuo Fujii
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases | Health Technology |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
















